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Mesangiogenic progenitor cells (MPCs) are a very peculiar population of cells present
in the human adult bone marrow, only recently discovered and characterized. Owing
to their differentiation potential, MPCs can be considered progenitors for mesenchymal
stromal cells (MSCs), and for this reason they potentially represent a promising cell
population to apply for skeletal tissue regeneration applications. Here, we evaluate
the effects of surface nanotopography on MPCs, considering the possibility that this
specific physical stimulus alone can trigger MPC differentiation toward the mesenchymal
lineage. In particular, we exploit nanogratings to deliver a mechanical, directional
stimulus by contact interaction to promote cell morphological polarization and stretching.
Following this interaction, we study the MPC-MSC transition by i. analyzing the
change in cell morphotype by immunostaining of the key cell-adhesion structures and
confocal fluorescence microscopy, and ii. quantifying the expression of cell-phenotype
characterizing markers by flow cytometry. We demonstrate that the MPC mesengenic
differentiation can be induced by the solely interaction with the NGs, in absence of
any other external, chemical stimulus. This aspect is of particular interest in the case
of multipotent progenitors as MPCs that, retaining both mesengenic and angiogenic
potential, possess a high clinical appeal.
Keywords: mesangiogenic progenitor cells, mesenchymal stromal cells, bone marrow culture, polyethylene
terephthalate, nanograting
INTRODUCTION
Mesenchymal stromal cells (MSCs) have been the object of extensive research for decades, due to
their intrinsic clinical value. Mesangiogenic progenitor cells (MPCs), instead, were only recently
discovered and characterized. They were firstly co-isolated, in different percentages, with MSCs
in human adult bone marrow cultures applying autologous serum (Petrini et al., 2009); later,
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the establishment of specific culture conditions selective for
MPCs allowed the isolation of these cells with a high grade
of purity (>95%). Specifically, when human bone marrow
mononuclear cells (hBM-MNCs) are cultured in basal medium
supplemented with human serum (HS) on hydrophobic surfaces,
it is possible to select slow-cycling MPCs after 6 days of
culture (Trombi et al., 2009) because this was the only cell
population present in the initial preparation capable of attaching
on hydrophobic plastic dishes.
Phenotypically, MPCs are easily distinguishable from
MSCs for their fried egg-shape morphology and peculiar
immuophenotype characterized by the positivity to CD18, CD31
and nestin as well as negativity to the MSC markers as CD73
and CD90. Interestingly, as MPCs initially showed to retain
mesengenic, cardiomyogenic, and angiogenic potential, these
cells were firstly named “mesodermal” progenitor cells. Later
on, the mesengenic potential was definitively demonstrated and
finely described in two steps of differentiation, once cultured
in specific pre-formulated media for MSC expansion. Namely,
MPCs firstly differentiate into slow cycling CD90+/nestin+
cells (earlyMSCs), activating non-canonical Wnt signaling, that
generate exponentially growing MSC-like cells (lateMSCs) after
prolonged culture time (Fazzi et al., 2011). Similarly, angiogenic
potential ofMPCswas demonstrated. Also in this case the process
involves two steps: first, MPCs are induced to VEGF-stimulated
angiogenic sprouting; then they complete differentiation by
forming capillary tube-like structures in 3D-cultures. Conversely,
the cardiomyogenic potential was not definitively demonstrated,
suggesting changing the MPC nomenclature into “mesangiogenic
progenitor cells” (Montali et al., 2016) in spite of “mesodermal”
progenitor cells. MPCs have been demonstrated deriving from a
unique bone marrow cell population named Pop#8 (Pacini et al.,
2016). This cell population has been sorted from adult human
bone marrow as CD45lowCD31brightCD64brightCD14neg and
showed similarities to monocytoid progenitors. Moreover, MPC
morphology and phenotype partially resemble macrophages
suggesting that these mesangiogenic progenitors and their in
vivo counterparts (Pop#8) could belong to the hemopoietic
compartment. Similarly, plasticity of peripheral monocytes and
macrophages has been demonstrated. Some groups reported
evidences showing that these cells could differentiate into
fibroblast-like and collagen-producing cells called “fibrocytes”
which participate in tissue repair, mainly sustaining fibrosis
(reviewed in Bucala, 2015). Nonetheless, demonstration of
genuine mesengenic potential (osteogenic, adipogenic, and
chondrogenic) of fibrocytes is still lacking, restricting their
tissue repairing potential to scar formation, while sustaining
to angiogenesis has been reported for these cells but only as
paracrine secretion of pro-angiogenic factors (Grieb et al., 2011).
Moreover, fibrocytes derived from peripheral CD45brightCD14+
monocytes also characterized for the expression of CD11b, C11c,
CD13, and CD16 (Pilling et al., 2009), which have not been
detected on bone marrow-derived CD45lowCD14neg Pop#8.
As MPCs can be considered progenitors for MSCs, they
potentially represent a promising cell population to apply for
skeletal tissue regeneration applications. Cell based medicinal
products obtained by hBM-MNCs cultured in autologous serum
were applied in the treatment of upper limb nonunions
(Giannotti et al., 2013). In this paper, authors reported consistent
percentages of MPCs (1–10%) within the expected MSC
population, although not all of the conditions for MPC selection
were complained. Nonetheless, it was suggested that the MPC
fraction possibly contributed to the long-term healing reported
in the treated patients. This hypothesis arose from the reported
MPC plasticity suggesting that, once implanted, these cells could
support osteogenesis differentiating into earlyMSCs, as well
as contributing to the neo-vascularization of the engineered
construct thank to their angiogenic potential.
In order to better investigate and exploit this possible
therapeutic scenario in the field of orthopedics, further
experiments should be performed in vitro in order to predict
the MPC differentiation fate resulting from different physico-
chemical stimulations that selectively mimic specific aspects of
the in vivomicro-environments.
Bone tissue homeostasis represents a complex biological
process finely regulated by humoral stimuli as hormones,
growth factors and cytokines as well as by cell-cell and
cell-matrix contact interactions (Florencio-Silva et al., 2015).
Thus, optimal bone regenerative therapy should enhance
mineralized tissue healing through enrichment of the bone
defect with a micro/nanostructured matrix scaffold to support
the wound, with cells that will give raise to osteoprogenitors
and proper biochemical stimuli. Recently, a factor controlling
the fate of many osteocompentent cells has been introduced,
taking in consideration that micro- e nano-topography of
the bone architectures could have a role in the regulation
of the activity of the bone cells trough the activation
of cellular mechanotransduction mechanisms mediated by
adhesion molecules (Green et al., 1995; Zohar, 2012). In
particular, this complex bone architecture resulted mainly
sustained by collagen and hydroxyapatite (HA), which together
form a highly aligned composite matrix that contribute to the
toughness and strength of bone itself (Weiner et al., 1999;
Kerschnitzki et al., 2011). Collagen triple helices are typically
around 300 nm long and 1.5 nm in diameter (Weiner et al.,
1999) conferring a linear topography to the bone structure
at the nanoscale. Many studies reported the influence of
nanotopography to the biology of osteoprogenitors (Dalby et al.,
2007; McMurray et al., 2011; Janson et al., 2014) suggesting to
control their differentiation applying nanostructured surfaces of
orthopedic implants.
MPCs showed particular adhesion properties sustained by
podosome-like structures, that were applied for the definition of
a MPC selective culture method (Trombi et al., 2009). Further
studies demonstrated that gelsolin-served F-actin podosomial
structures were re-organizedn in paxillin-served F-actin stress
fibers, during the mesengenic differentiation of MPCs (Pacini
et al., 2013), suggesting that topographical stimuli could play a
crucial role in the MPC fate.
The aim of this study is evaluating the effects of surface
nanostructuring on MPCs, considering the possibility that the
nanotopography alone can trigger the MPC differentiation
toward the mesenchymal lineage. In particular, we exploited
nanogratings to deliver a mechanical, directional stimulus by
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contact interaction to promote cell morphological polarization
and stretching. Following this interaction, we studied the MPC-
MSC transition by (i) analyzing the change in cell morphotype by
immunostaining of the key cell-adhesion structures and confocal
fluorescence microscopy, and (ii) quantifying the expression of
cell-phenotype characterizing markers by flow cytometry.
MATERIALS AND METHODS
Nanograting Fabrication
NGs were fabricated by thermal nanoimprinting lithography
(NIL) on copolymer 2-norbornene ethylene cyclic olefin
copolymer (COC) foils (IBIDI, Martinsried, Germany). COC
was chosen because of its well-documented biocompatibility
and optimal optical properties for high-resolution fluorescence
microscopy. NIL is based on the combination of pressure and
heat, which aids the transfer of the chosen pattern from a
rigid mold to thermoplastic materials. Molds were fabricated
by electron beam lithography (EBL) and reactive ion etching
(RIE) techniques as previously reported (Cecchini et al., 2007).
COC foils were imprinted using an Obducat Nanoimprint 24
system (Obducat, Sweden). After cleaning with nitrogen flow, the
substrates were placed on top of the silicon molds and softened
by raising the temperature up to 150◦C. A pressure of 50 bar
was then applied for 5 min before cooling down to 70◦C, that
is below the glass transition temperature of the copolymer (Tg=
134◦C). Finally, the pressure was released and the mold detached
from the substrate with a scalpel. The imprinted substrates were
quality checked by optical microscopy and attached to the bottom
of hollowed 35 mm Petri dishes by using silicone glue (RS
Components RS692–524).
Donors and Sample Collection
Human bone marrow blood samples were collected, after written
consent, from 12 patients (5 Male/6 Female, median age 64)
during orthopedic surgery for hip replacement. The study has
been performed according to the declaration of Helsinki and
to the approval of the local ethical committee of “Azienda
Ospedaliero-Universitaria Pisana.” A 20 ml syringe containing
500 U.I. of heparin was used to aspirate 10 ml of fresh tissue
immediately after femoral neck osteotomy and before femoral
reaming. Samples were promptly sent to the cell culture facility
and processed soon after.
MPC Preparation and Characterization
Cell Preparation
MPCs were obtained from hBM applying selective culture
conditions, according to the previously reported method
(Trombi et al., 2009; Montali et al., 2016). Briefly, bone
marrow blood samples were diluted 1:4, carefully stratified on
Ficoll-PaqueTM Premium (GE Healthcare, Uppsala, Sweden)
and centrifuge at 400 g for 30′. hBM mononuclear cells
(hBM-MNCs) were collected at the interface of the density
gradient, washed in Dulbecco’s modified phosphate saline
buffer (D-PBS, Thermo Scientific, Carlsbad, USA-CA) and
resuspended in Dulbecco’s modified Eagle medium (DMEM,
Thermo Scientific) supplemented with 10% of pooled human
type AB serum (PhABS, Lonza, Basel, Switzerland), 1:100
GlutamaxTM (Thermo Scientific) and 100 µU/ml of penicillin
and streptomycin (Thermo Scientific). Cell concentration and
vitality were determined by Bürker hemocytometer. From 30
× 106 to 60 × 106 hBM-MNCs were then plated in a T75
culture flask for suspension cultures (Greiner Bio-one, Monroe,
USA-NC) and incubated at 37◦C and 5% CO2 for 48 h in
DMEM/10%PhABS. Cells in suspension were removed with the
medium change and then adherent cell were maintained in
culture for 6 days. At the end, medium was discard, flasks were
washed with D-PBS and 1,5 ml of TrypLE R© Select detaching
solution (Thermo Scientific) was applied for 10′ to collect
MPCs.
Flow Cytometry
3 × 105 freshly isolated MPCs were processed for
immunophenotyping and incubated with anti-CD11c
VioBlue R©-conjugated, anti-CD18 PE-conjugated, anti-CD31
PE/Cy7-conjugated and anti-CD90 APC-conjugated (all from
Miltenyi Biotec, Bergisch Gladbach, Germany) for 30′ at 4◦C
in the dark. Cells were then washed with MACSQuant R©
Running Buffer (Miltenyi Biotec) and resuspended in 500 µl
of the same buffer for data acquisition in MACSQuant R© Flow
Cytometer (Miltenyi Biotec). Data were acquired and analyzed
byMACSQuantify R© analysis software (Miltenyi Biotec). Samples
with percentage of CD11c+CD18+CD31+CD90neg lower than
95% were excluded from the study.
Nestin Detection and F-Actin Organization
From 8 × 105 to 1.6 × 106 hBM-MNCs were seeded in 2-
well culture chamber slides (Thermo Scientific) and cultured
in DMEM/10%PhABS for 6 days, as described above. Cultures
were then washed twice in D-PBS and MPCs were fixed in
paraformaldehyde 4% for 15′. Permeabilization was performed
by incubation in Triton X-100 0.5% (Sigma Aldrich) for 15′, after
the removal of the fixative by extensive wash in D-PBS. Slides
were blocked applying Image-iTTM FX signal enhancer (Thermo
Scientific) and incubated with anti- human nestin monoclonal
antibody (Abcam, Cambridge, UK) overnight. Antibody excess
was removed by washing in Triton X-100 0.5% and slides were
then incubated with AlexaFluor R© 488-conjugated secondary
antibody for 1 h. F-actin staining was performed by AlexaFluor R©
555-conjugated phalloidin (Thermo Scientific) for 20′. The slides
were finally mounted with ProLong R© anti-fade reagent with
DAPI and pictures were taken using an inverted fluorescence DM
IRB microscope (Leica, Wetzlar, Germany) equipped with LAS
AF image analysis software (Leica).
Mesengenic Differentiation by Pre-formulated
Medium
Freshly detached MPCs were seeded in T75 flasks (20,000
cells/cm2) and let adhere overnight in DMEM/10%PhABS. The
day after the medium was changed with MesenPRO R© RS
medium (Thermo Scientific) and the cells were cultured until
confluence (P1-MSCs). Cells were then detached by enzymatic
digestion with TrypLE R© Select and sub-cultured at 5000 cells/cm
in new T75 flasks for flow cytometry analysis, and in 2-well
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culture chamber slides for the detection of nestin (performed at
confluence, P2-MSCs).
MPC Culture on T2 Nanogratings
Freshly isolated MPCs were resuspended and adjusted to 40,000
cells/ml in DMEM/10%PhABS, then a cell suspension volume
of 500 µl was seeded into four T2 nanostructured inserts, in
a drop. Cells were let adhere for 4 h, then additional fresh
medium (1.5 ml) was added and cells were cultured for 7
days. In parallel, cultures have been performed on four “FLAT”
inserts; additional cultures were also prepared in standard 6-
wells plates for suspension cultures, in order to evaluate the
spontaneous cell differentiation (marked as “CTRL”). For flow
cytometry quantification of the mesengenic differentiation, the
cells cultured onto the three different substrates were detached
by TrypLE R© Select digestion solution, washed in MACSQuant R©
Running Buffer (MiltenyiBiotec), and incubated with the
monoclonal antibodies, as described above. The acquisition
and analysis were performed applying dot-plot template set up
for MPC/P2-MSCs analysis. Mesenchymal differentiation was
evaluated by calculating the ratio between events with MSC-
associated phenotype, detected in R2 gate, and MPC-related
events detected in R1 gate (MSC/MPC).
Statistical Analysis
Data were reported as average value ± the standard error
of the mean (mean ± SEM), obtained from at least three
independent experiments. Data were statistically analyzed by
GraphPad PRISM 6.00 program (GraphPad Software, San Diego,
CA, USA). For parametric data, Student’s t-test (unpaired, two-
tailed) or One-Way ANOVA (Tukey’s or Dunnett’s multiple
comparison test) analysis were used; the mean values obtained
in each repeated experiment were assumed to be normally
distributed about the true mean. Statistical significance refers to
results where p < 0.05 was obtained. Further details on data
representation and statistics are reported in the figure legends.
RESULTS
Nanograting Fabrication and
Characterization
Three different substrates were chosen to study MPC
differentiation toward the MSC phenotype. The substrates
were produced starting form 200-µm-thick COC films by
hot embossing (Figure 1), as detailed in the Materials and
Methods section. This process provided us with nanostructured
surfaces covering macroscopic areas (= 1 cm2), well suitable
for fluorescence microscopy and cell/molecular biology studies.
Two surface geometries were fabricated, the first having an
embossed nanograting (named T2) while the second was
obtained with the same thermal and pressure cycle but using
a flat mold (i.e., a silicon polished wafer). This last substrate is
named FLAT and has been used as control condition for the
T2 surface in each experiment. T2 is characterized by ridge
and groove width of 1000 nm, and depth of 350 nm. All the
COC surfaces were proven to be adhesive for MPCs without
requiring any chemical functionalization but plasma activation.
In this study and previously (Tonazzini et al., 2013; Jacchetti
FIGURE 1 | (A) Scheme of the substrate fabrication process. COC foils are
placed on nano/microstructured molds and imprinted following a single
heating and pressure cycle. Scanning electron microscope (B) and atomic
force microscope (C) representative images of a T2 substrate. Scale bars = 2
um; The color-scale in (C) goes from 0 (black) to 400 nm (white).
et al., 2014) we did not find any cytotoxicity originating by either
the surface topographical modification or by the material itself.
Finally, standard tissue culture Petri dishes were also used as
control condition for the FLAT substrates in order to verify
that the material itself did not cause the MPC-MSC transition.
Summarizing, three different substrates were exploited for this
study, the T2 and FLAT (both in COC), and a standard plastic
Petri dish (named CTRL).
MPC Culture Characterization
All of the bone marrow samples could generate MPCs
(Figure 2A), that were isolated by applying the previously
reported method (Trombi et al., 2009; Montali et al., 2016).
As expected, culturing hBM-MNCs for 6 days under selective
culture conditions led to monomorphic cultures of adherent
cells with a peculiar fried egg-shape morphology (Figure 2A.1).
These cells were then characterized as MPCs for their intense
expression of nestin (green in Figure 2A.2) and the typical dotted
distribution of F-actin, that reveals numerous podosome-like
structures (red in Figure 2A.2). Also flow cytometry confirmed
the expected immunophenotype characterized by the positivity
to CD31 (PECAM), CD18 (Integrin β2), CD11c (Integrin αX)
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FIGURE 2 | Isolation and characterization of hBM-derived MPCs. Culturing hBM-MNCs for 6 days under MPC selective conditions lead to almost homogenous
population of rounded and highly rifrangent adherent cells (A.1). These cells were definitively characterized as MPCs for their intense positivity to nestin (green in A.2)
and for the presence of numerous podosome-like structures characterized by the dotted distribution of F-Actin (red in A.2). Flow cytometry confirmed the MPC
phenotype on approximately all analyzed cells (A.3), which were displayed in the lower right quadrant of the CD90 vs. CD31 dot-plot (“R1” green box). After two
passages under mesengenic differentiating conditions (P2-MSCs) the cultures were constituted by proliferating and fibroblastoid MSC-like cells (B.1) and nestin was
no longer detected (B.2). All MPC-related markers resulted undetectable by flow cytometry on P2-MSCs (B.3), which expressed high levels of CD90, occupying the
upper left quadrant of the CD90 vs. CD31 dot-plot (“R2” blue box).
and the lack of CD90 expression (Figure 2A.3). Flow cytometry
was then applied to determine the purity of MPC cultures
before subculture the cells on NGs. Most of the analyzed cell
preparations revealed MPC percentages higher than 95% (mean
96.5 ± 3.2%, n = 10), determined applying the R1 gate on
CD90 vs. CD31 dot-plot (green box in Figure 2A.3), and were
then processed for subsequent culture. Otherwise, two MPC
primary cultures revealed purity lower than 95% (data not
shown) with a consistent percentage (10 and 8%) of MSC-like
cells, determined applying the R2 gate (blue box in Figure 2A.3).
These latest two cell preparations were excluded from the
study.
Specific Formulated Media Induced
Differentiation of MPCs
In order to verify the differentiation potential of the isolated
MPCs, two passages of mesengenic differentiation were
applied. After 2 weeks of culture in MesenPRO R© RS medium,
differentiated cells (P2-MSCs) showed a fibroblastoid and
spindle-shaped morphology, typical of MSC-like cells
(Figure 2B.1). F-actin resulted re-organized in stress-fibers
(red in Figure 2B.2), while very low levels of nestin expression
was reported in few rare cells. Flow cytometry revealed almost
homogeneous culture of CD90-positive cells, lacking MPC-
related markers as CD31, CD18, and CD11c (Figure 2B.3).
As a consequence, in the CD90 vs. CD31 dot-plot these cell
events were plotted in the R2 gate. In order to definitely confirm
the MSC nature of the differentiated cells, P2-MSC cultures
were exposed to adipogenic as well as osteogenic differentiating
conditions, and respectively the lipid droplet accumulation and
calcium deposition were report for the cultures investigated (n=
10, data not shown).
MPCs Interact with NGs
Initial cell attachment on T2 nanostructures was not significantly
altered. After the 4 h incubation, most of the seeded cells
resulted firmly adherent to the substrate surfaces without any
noticeable difference with respect to those on FLAT or CTRL.
After overnight incubation, MPC morphology resulted highly
conserved, with cells maintaining the typical rounded fried egg-
shape. Nuclei appeared slightly oval with compact chromatin,
and did not show any alignment to the grating direction.
Conversely, all characteristic podosome-like structures resulted
aligned in correspondence to the NG crests, while resulting
randomly oriented in correspondence of the not patterned areas,
similarly to those of the cells seeded on FLAT or CTRL (Figure 3).
Moreover, numerous filopodia, occasionally detected on some
MPCs, showed the ability to align to the NGs.
Nanogratings Trigger MPC Differentiation
toward MSC-Like Cells
In order to evaluate the effect of the solely topography of the
T2 on the MPCs transition to MSCs, the cell mortally related to
the re-plating procedures or to the different substrate chemical
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 December 2016 | Volume 4 | Article 144
Antonini et al. Nanotopography and MPC Differentiation
FIGURE 3 | MPCs interact with NGs at the adhesion level. After overnight incubation on nano-structured T2 gratings, most of the seeded MPCs resulted firmly
attached and showed the numerous podosomes aligned to the grating direction (white arrows) and in correspondence to the crests. Similarly, filopodia showed an
alignment to the grating direction. Fluorescence images were acquired by confocal microscopy and immunostaining of F-Actin; arrows show grating direction, and
area. The bottom row shows cells on FLAT (left) and CTRL (right).
composition have been taken in consideration, eliminating the
experiments that showed reduced vitality (<80%) in CTRL
and in FLAT cultures (Figure 4A pale red area). For the same
reason, possible spontaneous differentiation has been evaluated,
and experiments in which CTRL or FLAT cultures showed a
MSC/MPC ratio higher than 0.1 where excluded from the study
(Figure 4B). After this evaluation eight experiments showed
consistent vitality and absence of spontaneous differentiation
(Figure 4C), while two experiments were excluded from the
analysis (Figure 4D). After 7 days of culture on FLAT inserts,
no change in MPC morphology or phenotype were reported
and few events were detected in the R2 gate, in all validated
experiments (Figure 5A). Conversely on T2 NGs, evident signs
of differentiation were proven by numerous elongated MSC-like
cells oriented along the grating direction, and by a consistent
population expressing MSC-associated phenotype, detected in
the R2 gate (Figure 5B). Quantitatively, normalized MSC/MPC
ratio resulted significantly higher in cultures performed on T2
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FIGURE 4 | Evaluation of cell viability and spontaneous differentiation. (A) Percentage of viable cells (PI-negative) for the different substrates. (B) Spontaneous
differentiation, evaluated by ratio between MSC and MPC percentages, in control sub-cultures and “FLAT” conditions. Red and green areas indicate data from
experiments that were considered valid (i.e., viability >80% and MSC/MPC <0.10 on controls). (C) Dot plots of representative sample included in the study. (D) Dot
plots of representative samples excluded from the study for its consistent spontaneous differentiation in non-nanostrucutred controls.
NGs (p< 0.05), with themean value (0.19± 0.05) triplicated with
respect to that measured on FLAT (0.062± 0.015, Figure 5C).
DISCUSSION
Implant osteointegration represents the key of success in most of
the orthopedic procedures. It has been defined as the formation
of structural and functional interconnection between the implant
and the host bone (Albrektsson et al., 1981). In order to promote
osteointegration, many materials and new fabrication processes
have been proposed to obtain a high porous implant surface
on which the bone cells could adhere and growth (Agarwal
and García, 2015). Nowadays, the gold standard is represented
by devices made by trabecular metal, which can mimic the
bone microstructure and make available an ideal space for
cellular colonization and revascularization of the neoformed
bone tissue. However, an important limit of the implants and
materials currently used in orthopedic surgery is that they present
micron-sized textures while the bone is a nanostructured tissue.
Collagen and hydroxyapatite, for example, provide a unique
nanostructured scaffold for proteins and bone cell interactions.
For these reasons, nanomaterials have been proposed with the
aim of improving surface properties and creating an environment
more conducive for osteoblast function and bone ingrowth (Tran
and Webster, 2009; Parchi et al., 2013). Sub-micrometer sized
features on traditional implants can control protein absorption
and decrease scar tissue growth, bacterial infection and promote
appropriate tissue growth. Moreover, they can also guide cell
differentiation through physical stimulation, by a process called
mechanotrasduction in which physical forces are converted into
biochemical signals that are the finally integrated to give specific
cellular response (Duncan and Turner, 1995).
Substrate nanotopography has been demonstrated to affect
the biology of MSCs in vitro and the possibility of controlling
the phenotype of these cells by just physically modifying the
substrate topography represents one of the most promising
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 December 2016 | Volume 4 | Article 144
Antonini et al. Nanotopography and MPC Differentiation
FIGURE 5 | Nanograting induced MPC-to-MSC differentiation. Representative flow-cytometry scatter plots and microscopy images of MPCs cultured on Flat (A)
and T2 (B). (C) Ratio of viable MSCs over viable MPCs normalized to the average value measured on Flat (*p < 0.05, t-test).
innovations in the field. However, the majority of the studies
was conducted with bone marrow derived mesenchymal stromal
cells (BM-MSCs). Very recently our group demonstrated that
nanogratings, alternate lines of sub-micrometer sized ridges
and grooves, can effectively polarize BM-MSCs by pure contact
interaction (Antonini et al., 2014), and promote enhanced osteo-
differentiation with respect to flat surfaces (Antonini et al.,
2016). There is indeed a large consensus considering BM-MSCs
as the progenitors of the skeletal tissue related cell lineages
for their ability to differentiate into adipocytes, osteoblasts
and chondroblasts (Keating, 2012). This study also shows
that after interaction with nanograting, BM-MSCs retain their
osteodifferentiation potential.
Nonetheless, BM-MSCs represent a heterogeneous cell
population isolated in vitro, in which the composition and cell
biology are strongly affected by the isolating and expanding
procedures (Phinney, 2012). Alongside the variability related
to donors (Deasy et al., 2007; Siegel et al., 2013) and culture
methods (Sharma et al., 2014), multiple origins of BM-
MSCs were hypothesized and supported by several experiments
demonstrating that genuine MSC cultures can be obtained by
different BM subpopulations in vivo and in vitro, (reviewed in
Pacini, 2014).
Remarkably, the MSC frequency in human normal bone
marrow has been estimated only about the 0.001 and 0.01% of
the mononuclear cells. Conversely, the MPCs frequency, and its
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in vivo counterpart denominated Pop#8, results from two to three
logs higher (Trombi et al., 2009; Pacini et al., 2016).
Therefore, it is reasonable to hypothesize that the effects
exerted by the nanostructured surfaces on MPCs can more
strongly affect implant osteointegration than those on very
small cell populations such us “skeletal stem cells” (SSCs)
(Bianco and Robey, 2015) or CD271+CD140low/− (Li et al.,
2016), today considered the bona fide ancestors of BM-MSCs
in vivo. Our results indicate that nanogratings can promote
MPC to MSC transition, suggesting an in vivo scenario in
which osteointegration is possibly promoted following MPC
to MSC transition and nanograting-driven MSC osteogenic
differentiation.
It is known that the substrate directionality stimulus
is optimally delivered to many kind of undifferenziated
cells, including MSCs, which in turn elongate and align
to the nanograting lines. This polarization occurs also at
level of cytoskeleton fibers and, though to a lesser extent,
of nuclei. In this context, an elegant mechanistic model
was proposed suggesting that an increased binding of
integrins to ECM proteins would lead to increased FAK
recruitment to the adhesion plaque inducing downstream
ERK-dependent differentiation (Yee et al., 2008) This model
provides an insight into the mechanisms of focal adhesion-
dependent differentiation that might apply also to the
MPC-MSC transition, and shows that nanotopographical
surface modifications may directly regulate stem cell
differentiation. Substrate topography can, indeed, interfere
with focal-adhesion maturation and shaping, which in
turn reflects on cellular mechanical stress distribution and
shaping.
Interestingly, here we have demonstrated that the MPC
mesengenic differentiation could be induced by the solely
interaction with the T2 NGs, in absence of any other external
stimuli. This aspect opens an interesting issue regarding the
heterogeneity of culture expanded MSCs. In fact, it has been
hypothesized that expanding MSCs from unfractionated “crude”
bone marrow cell suspensions, in uncontrolled open culture
systems, could lead to significantly different cell products with
unpredictable biological properties because ofmildmodifications
in the culture determinants or even to environmental fluctuations
during cell expansion (Pacini, 2014). Data presented here suggest
that differences in the intrinsic nanotopography of the culture
surfaces, correlated to the materials or to the production
processes, should be consider an additional culture determinant
that might increase the variability of the final product. Thus,
it might be possible that some pre-clinical data collected on
MSCs expanded in flasks from bone marrow are not predictive
for the therapeutic value of the same cell population cultured
in bioreactors (i.e., equipped with hollow fibers), as their
proliferation and differentiation potential could be altered by the
specific micro- and/or nanotopography of the contact surfaces.
Concluding, the seminal findings reported here sustain the
fascinating hypothesis of a topographic control of progenitor cells
fate by specific designs of nanostructured surfaces. This aspect
is of particular interest in the case of multipotent progenitors as
MPCs that, retaining both mesengenic and angiogenic potential,
possess a high clinical appeal.
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